Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk

Abstract

The Royal College of Surgeons (RCS) rat is a widely studied animal model of retinal degeneration in which the inability of the retinal pigment epithelium (RPE) to phagocytize shed photoreceptor outer segments leads to a progressive loss of rod and cone photoreceptors. We recently used positional cloning to demonstrate that the gene Mertk likely corresponds to the retinal dystrophy (rdy) locus of the RCS rat. In the present study, we sought to determine whether gene transfer of Mertk to a RCS rat retina would result in correction of the RPE phagocytosis defect and preservation of photoreceptors. We used subretinal injection of a recombinant replication-deficient adenovirus encoding rat Mertk to deliver the gene to the eyes of young RCS rats. Electrophysiological assessment of animals 30 days after injection revealed an increased sensitivity of treated eyes to low-intensity light. Histologic and ultrastructural assessment demonstrated substantial sparing of photoreceptors, preservation of outer segment structure, and correction of the RPE phagocytosis defect in areas surrounding the injection site. Our results provide definitive evidence that mutation of Mertk underlies the RCS retinal dystrophy phenotype, and that the phenotype can be corrected by treatment of juvenile animals. To our knowledge, this is the first demonstration of complementation of both a functional cellular defect (phagocytosis) and a photoreceptor degeneration by gene transfer to the RPE. These results, together with the recent discovery of MERTK mutations in individuals with retinitis pigmentosa, emphasize the importance of the RCS rat as a model for gene therapy of diseases that arise from RPE dysfunction.T he Royal College of Surgeons (RCS) rat strain displays an unusual retinal phenotype in which shed photoreceptor (PR) outer segment (OS) debris accumulates in the subretinal space (1). PR disk shedding normally commences at postnatal day (P)12 in the rat (2), and an OS debris layer is readily apparent in the eyes of RCS animals at P20. Genetic chimera studies suggest that the defect is a cell-autonomous function of the RPE, not the PRs (3). Indeed, in vivo (4) and RPE cell culture studies (5) revealed a defect in the ability of RCS RPE to phagocytize shed OS membranes. Despite the RPE-specific nature of the defect, death strikes the PRs first, through the process of apoptosis (6). The time course of PR degeneration is rapid, beginning around P20, with few PR nuclei remaining in the outer nuclear layer (ONL) by P60. Thinning and atrophy of the RPE begins after onset of PR degeneration. The cause of PR cell death is not well understood; the debris zone acting as a diffusion barrier to metabolites (7), disruption of the interphotoreceptor matrix (8), and PR hypoxia due to diminished oxygen diffusion (9) have been proposed as explanations.In contrast to the extensively studied retinal phenotype of the RCS rat, the nature of the genetic defect has remained obscure until recently. Early genetic linkage studies showed that the phenotype is complet...

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

“…8,11 Immune responses to Ad vectors appear to limit their effectiveness in the eye to around 3 weeks. 10,14 Although gene replacement therapy using an AAV-2 vector is more effective than that using an Ad vector, 11 the late onset of AAV-mediated expression is likely to compromise its efficacy.…”

Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives

“…The first demonstration of successful rescue of both a functional cellular defect (phagocytosis) and a photoreceptor degeneration was achieved by recombinant adenovirus-mediated gene transfer to the RPE. 78 More recently, it was demonstrated that rAAV-mediated gene transfer slows photoreceptor loss in this model. Subretinal injection of rAAV-2/2mertk prolong photoreceptor cell survival in the RCS rat, as assessed by histology.…”

Revisiting the role of erythropoietin for treatment of ocular disorders

“…126,127 MSCs are a type of adult stem cells 11 that have been intensively explored by Eliopoulos et al 128 for delivery of EPO to correct anemia successfully in mice. 129 We have previously transplanted MSCs derived from human Wharton's Jelly into the subretinal layer of the Royal College of Surgeon's rats and found that these cells had the ability to differentiate into retinal cells, which was in concurrance with other study.…”